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ABSTRACT 
Blood clotting is an important and vital process that takes places in humans, animals and birds. At the same time blood clots sometimes 
considered an issue when developed in the circulatory system due to failure of hemostasis causes vascular blockage and leads to serious 
consequences in thrombolytic diseases such as acute myocardial or cerebral infarction which may cause death. Certain substances like 
Alteplase, anistreplase, streptokinase, urokinase, tissue plasminogen activator, Heparin and Aspirin are used as clot dissolving agents. Plants 
have also been proved to perform such activity. Calotropis gigantea L. is a traditional medicinal plant with several pharmacological 
properties belongs to the family Apocyanaceae of Asclepiadaceous was investigated for its efficacy for blood clot dissolving activity under in 
vitro conditions when incorporated into carbomer based gels. The ethanolic extract of the leaves of C. gigantea was prepare by soxhlation 
which upon analysis reported to contain alkaloids, glycosides, flavonoids, tannins, terpenoids and saponins as usual components as were 
reported in earlier investigations. There were 3 gels with ethanolic leaf extract C. gigantea with 1 mg, 0.5 mg and 0.25 mg per gram of 1% 
Carbopol-940 gel containing methyl paraben, glycerol and water. The two gels containing sterile distilled water and 0.1 mg per gram gel 
streptokinase enzyme served as –ve and positive controls respectively. The in vitro thrombolytic of clot dissolving activity war performed on 
goat blood collected from slaughter houses. From the results the percentage clot dissolving activity of gels containing 1 mg, 0.5 mg and 0.25 
mg C. gigantea extract per gram were reported as 34%, 27% and 14% respectively considered significant when compared to the activity of 
standard streptokinase in the gel. The activity of these experimental gels describes the possibility of development of new safe, and non 
reactive topical anti-clot gel products using herbal or plant components like C. gigantea extracts. 
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INTRODUCTION 
Referring to the article published in 1879, blood clotting is 
an important and vital process that takes places in humans, 
animals and birds1. Maintenance of normal blood flow 
requires equilibrium between procoagulant and 
anticoagulant factors within the blood circulatory system. 
But when procoagulant activity preponderates, results into 
the formation of blood clots where tissue damage becomes 
a factor in the process in general2. Blood clotting is a 
complex interaction of various mechanisms, where 
activation of the coagulation, fibrinolytic systems, 
disruption of the vascular endothelium, and the 
generalized activation of cellular mechanisms leads to 
clotting on the surface of monocytes and platelets in 
circulation3. Blood clots sometimes considered an issue 
when developed in the circulatory system due to failure of 
hemostasis causes vascular blockage and leads to serious 
consequences in thrombolytic diseases such as acute 
myocardial or cerebral infarction which may cause death 4. 
Hereditary factors, primary or acquired, play a role in the 
development of thrombosis3. The breakdown of blood clots 
is referred to as thrombolysis or clot busting in 
pharmacological terms and that can be done by stimulating 
secondary fibrinolysis by plasmin through infusion of 
analogs of tissue plasminogen activator the protein that 
normally activates plasmin. Certain substances are used as 
Clot dissolving agents available in the market like 
Alteplase, anistreplase, streptokinase, urokinase and tissue 
plasminogen activator. Where moderately efficient Heparin 
and Aspirin are also available accelerating the lysis and 
prevent the reoccurrence of thrombus but are safe5. As per 
some literatures, anticoagulants that are being used 
presently shows not only the negative and life-threatening 
side effects but runs high in cost from therapeutic point of 
view, thus researchers and investigators are now finds 
their interest in exploring the natural resources in order to 
develop alternate novel agent that could perform similar 
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functions without any harm 6,7. According to World Health 
Organization (WHO), medicinal plants would be the best 
source to obtain variety of drugs, due to the presence of 
different chemicals used as phytomedicine, derived from 
different parts of the plants8. In recent studies, 
Campomanesia xanthocarpa, Alpinia conchigera, Lannea 
grandis Engl. Aglaonema hookerianum Schott. Tridax 
procumbens L. Nigella sativa, Capsicum frutescens, Brassica 
oleracea, Calotropis gigantea like plants have been proved 
to perform such activity9-12. Calotropis gigantea L. is a 
traditional medicinal plant has reported to have analgesic, 
antipyretic activity, antimicrobial, anti-diarrheal and 
cytotoxic, properties belongs to the family Apocyanaceae of 
Asclepiadaceous thrives habitat of Asian countries13. C. 
gigantea L. has been considered to cure cardiovascular 
diseases, skin diseases, use as anticancer, antifertility and 
antidote for snakebites in traditional system of medicine14-
17. This plant has also been investigated for thrombolytic 
activity12. Thus current preliminary study aimed at 
investigation efficacy of carbomer based gel prepared from 
ethanolic extracts of C. gigantia leaves blood clot dissolving 
activity under in vitro conditions. 
MATERIALS AND METHODS 
Sample collection and processing 
The leaves of C. gigantea were collected from local area 
around the Indore City and were authenticated with use of 
herbarium available in the college, literatures and images 
from web resources. The collected leaves were washed 
thoroughly with tap water, cleaned and dried at room 
temperature followed by grinding them into fine powder. 
These finely grounded leaf powders were subjected to 
phytochemical extraction.  
Phytochemical extraction and analysis 
The fine powdered leaves of C. gigantea were first defatted 
with petroleum ether at ambient temperature for 24 hours 
and then the defatted marc was further subjected to 
phytochemical extraction using Soxhlet extractor in 50% 
ethanol as solvent. The menstruum so obtained after 
extraction was allowed to concentrate in a boiling water 
bath to evaporate the solvent. The percentage yield of 
extraction and preliminary phytochemical analysis was 
done18-20.    
Preparation of carbopol based gel 
Stock of phytochemical extract was prepared in sterile 
distilled water with a concentration of 100 mg/ml. In 
present study the Carbopol gel were prepared with 
suitable modifications 21-23. The composition of the gel base 
used in present work is depicted in table 1. The stock 
concentration of 100 mg/ml crud phytochemical extract 
was prepared in sterile distilled water homogenized and 
degassed in ultrasonic bath which was used to be added in 
gel to make varied final concentrations of extract in per 
gram of gel. 
Table 1 Composition of Cabopol-940 gel base 
S.N. Composition Amount 
1 Water 100 ml 
2 Carbopol -940 1 gm 
3 Methyl paraben 200 mg 
4 Glycerol 1 ml 
5 Phyto extract stock As required 
 
In vitro clot dissolving activity 
The in vitro thrombolytic activity of prepared gels was 
done with some modifications5, 24, 25. The blood samples 
were collected from the slaughter houses where goat blood 
was used instead of human blood because of similarities in 
clotting properties. The blood samples were collected in 
1.5 ml microfuge and incubated at 37°C for 2 hours to allow 
the clot formation followed by removal of serum carefully 
and weight of the clot was measured. Now, to each of the 
pre-weighed clot in microfuge, 100 μl of prepared carbopol 
based gel containing extracts were added with the help of 
micropipette (from HiMedia) touching the surface of blood 
clot. A blank gel without any extract and a gel containing 
streptokinase were used as negative and positive control 
respectively. The set of experiment was incubated at 37 °C 
for 2 hours followed by observation in vitro thrombolytic 
activity. The liquid released after incubation was drained 
and remaining clot was washed with sterile distilled water 
and dried well to remove moisture followed by weighing 
the clot again to determine the percentage thrombolytic 
activity of gels compared to standard using following 
formulae;   
 
 
RESULTS AND DISCUSSION 
Preliminary phytochemical analysis 
The results of phytochemical extraction and analysis for 
the presence of phytoconstituents are more or less 
coincides with earlier investigations26-28. In present study 
the yield of extraction with hydro ethanolic solvent was 
18.1%. While this ethanolic extract of leave of C. gigantea 
was reported to contain alkaloids, glycosides, flavonoids, 
tannins, terpenoids and saponins as usual components as 
were reported in earlier investigations29. 
In vitro clot dissolving activity  
The in vitro clot dissolving activity of carbopol based gels 
shows promising results in development of 
biopharmaceutical purpose for therapeutic substances. 
There were 3 different concentrations of extracts in gels 
were used in present study whose percentage thrombolytic 
activity are depicted in table 2 compared to the standard 
streptokinase.
  
Table 2: In vitro clot dissolving activity of carbopol gel containing C. gigantea extract compared to gel containing 
Streptokinase 
S.N. Gels Designation Concentration Percentage Clot Lysis 
1 Gel-1 –ve Control with water NA 1.8% 
2 Gel-2 +ve Control with Streptokinase 0.1 mg/g gel 71% 
3 Gel-3 Test Gel with extract 1 mg/g gel 34% 
4 Gel-4 Test Gel with extract 0.5 mg/g gel 27% 
5 Gel-5 Test Gel with extract 0.25 mg/g gel 14% 
  
% Thrombolysis = 
Weight of clot after incubation 
Weight of clot before incubation 
× 100 
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The early reports on in vitro thrombolytic activity of C. 
gigantea extracts encouraged the test the similar effect of 
ethanolic extracts of C. gigantea leave when incorporated 
in any neutral gels in present study 30-31. In present study 
the in vitro blood clot dissolving activity of ethanolic leaf 
extract of C. gigantea in carbopol gel at a concentration of 1 
mg/g of gel was observed to be 34% which reduces with 
serial decrease in extract concentration in gels as 27% and 
14% with Gel-4 and Gel-5 respectively (Table 2). 
Strepotkinase at a concentration of 0.1 mg/ml generally 
produces a thrombolytic activity in range from 80 to 95% 
12, 32. In present study when it was incorporated in gel it 
showed an activity of 71% at similar concentration in gels 
that is optimum. The activity of varied concentration of 
extract with the activity streptokinase in gels, the 
dissolution of clot by extracts is considerable (Figure 1) 
 
Figure 1: Graphical representation of in vitro 
thrombolytic or blood clot dissolving potential of gels 
prepares containing streptokinase and ethanolic 
extract of C. gigantean. 
Food and Drug Administration (FDA) has approved several 
pharmaceuticals of plant origin, also several plants have 
been investigated earlier including C. gigantea for anti-
coagulant, anti-platelet and fibrinolytic activity where 
many claims that some herbs and food showing preventive 
effects on events of coronary blockage and stroke 33 ,34. 
Heavy external blood clots due to any tissue tear or 
rupture or large accidental wound development is also a 
problem sometimes when causing painful bandage. 
Incorporation of any pharmacological substance in gel are 
generally meant for topical applications and here the anti 
blood clot activity of carbopol based gel containing 
ethanolic extracts of C. gigantea leaves were effectively 
dissolving blood clot at all 3 different concentration under 
in vitro experiments. This property of C. gigantea leaf 
extract may be exploited in development of new 
biopharmaceutical and therapeutic agents upon further 
extensive investigation related to it are save use on 
animals and humans. 
CONCLUSIONS 
From the results of present investigation, it could be 
concluded that the phytochemical extracts of C. gigantea 
are rich in number of chemical components that posses the 
biological and pharmacological activities which has been 
also reported several times in early studies. The clot 
dissolving activity of extracts works when not only when 
use as sole component but also when incorporated in gels. 
Because of the significant inadequacies of the currently 
available thrombolytic agents of microbial origin 
sometimes imparting allergy effects where plant derived 
drugs are considered promising in development of new 
therapeutic agents. So, upon further extensive studies 
related to preparation of non reactive polymer based gels 
containing plant chemicals could be developed into a 
successful topical biopharmaceutical product with anti-clot 
activity.
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